glp-1 obesity drug news A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio How Supply and Demand for
Description
GLP-1 RAs significantly reduced the risk of MACE compared with placebo (hazard ratio [HR] 0.87, 95% confidence interval [CI] 0.770.98) in HF coexisting with T2DM
Skov J, Pedersen M, Holst JJ, Madsen B, Goetze JP, Rittig S, et al

Chris Serres: What the medications do is they produce this natural hormone, in the gut

Emerg Med Australas

Your care should be, too

This is not a prescription medication but should be discussed if you take other medications